Although rHu-EPO increases blood pressure in patients with chronic renal failure and cancer [37, 38], the mild event observed in one subject could be considered an isolated event within the framework of the study, considering that the rest of subjects preserved normal values. This evidence concerns the gene EPO and chronic kidney disease.